Durlobactam and its Impurities

Durlobactam is a novel β-lactamase inhibitor developed to combat multidrug-resistant Gram-negative bacteria, particularly Acinetobacter species. An antibiotic used to treat certain types of pneumonia caused by bacteria. Reference standards of Durlobactam API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.